Elizabeth Holmes requested a new trial on Tuesday, asserting in a court filing that a key witness for the prosecution now regrets the role he played in her conviction for investor fraud and conspiracy related to Theranos, her failed blood-testing startup.
The petition centers on the reliability of testimony provided by the former Theranos lab director Adam Rosendorff, who said he repeatedly raised concerns about the accuracy of blood tests that were being administered to patients during his tenure in 2013 and 2014. It is typical for defendants to make motions for a new trial after a guilty verdict.
Holmes, 38, was convicted on four felony counts of investor fraud and conspiracy earlier this year after a nearly four-month trial. The former CEO is currently free on bail but is facing up to 20 years in prison at a sentencing hearing scheduled for 17 October 2022 in San Jose, California.
The trial of Holmes, which took place in 2021, focused on charges that the former executive knowingly defrauded investors and patients of her blood-testing firm Theranos. Holmes claimed her technology could be used to carry out hundreds of medical tests using just a drop of blood, a claim later revealed to be false.
Balwani faced his own trial for similar charges this year. He was convicted on all 12 charges and will be sentenced on 15 November.
The Associated Press contributed to this report
